ASX - Delayed Quote AUD

PYC Therapeutics Limited (PYC.AX)

Compare
1.5200 0.0000 (0.00%)
As of 3:15:05 PM GMT+11. Market Open.
Currency in AUD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Expense
60,422.7110
60,422.7110
39,163.1230
30,207.7660
21,832.8480
Operating Income
-60,422.7110
-60,422.7110
-39,163.1230
-30,207.7660
-21,832.8480
Net Non Operating Interest Income Expense
746.7670
746.7670
54.5610
-8.1700
69.6760
Other Income Expense
21,565.4850
21,565.4850
15,752.0820
15,921.9680
3,133.1710
Pretax Income
-38,110.4590
-38,110.4590
-23,356.4800
-14,293.9680
-18,630.0010
Net Income Common Stockholders
-37,725.4110
-37,725.4110
-22,788.9850
-13,863.1590
-17,767.5860
Basic EPS
-0.01
-0.01
-0.01
-0.00
-0.01
Diluted EPS
-0.01
-0.01
-0.01
-0.00
-0.01
Basic Average Shares
3,528,071.0360
3,935,910.6230
3,248,815.1570
3,218,794.2700
3,128,452.4260
Diluted Average Shares
3,528,071.0360
3,935,910.6230
3,248,815.1570
3,218,794.2700
3,128,452.4260
Net Income from Continuing & Discontinued Operation
-37,725.4110
-37,725.4110
-22,788.9850
-13,863.1590
-17,767.5860
Normalized Income
-37,725.4110
-37,725.4110
-22,788.9850
-13,863.1590
-17,767.5860
Interest Income
795.9760
795.9760
81.8490
24.4250
108.4980
Interest Expense
49.2090
49.2090
27.2880
32.5950
38.8220
Net Interest Income
746.7670
746.7670
54.5610
-8.1700
69.6760
EBIT
-38,061.2500
-38,061.2500
-23,329.1920
-14,261.3730
-18,591.1790
EBITDA
-37,460.3690
-37,460.3690
-22,777.9740
-13,421.8680
-17,968.8170
Reconciled Depreciation
600.8810
600.8810
551.2180
839.5050
622.3620
Net Income from Continuing Operation Net Minority Interest
-37,725.4110
-37,725.4110
-22,788.9850
-13,863.1590
-17,767.5860
Normalized EBITDA
-37,460.3690
-37,460.3690
-22,777.9740
-13,421.8680
-17,968.8170
6/30/2021 - 11/17/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PAR.AX Paradigm Biopharmaceuticals Limited
0.4250
-4.49%
 
TRP.AX Tissue Repair Ltd
0.2550
-1.92%
 
VBS.AX Vectus Biosystems Limited
0.0770
0.00%
 
ZLD.AX Zelira Therapeutics Limited
0.6000
0.00%
 
ZICC.ST Ziccum AB (publ)
0.7460
-10.98%
 
PTX.AX Prescient Therapeutics Limited
0.0410
-2.38%
 
CYP.AX Cynata Therapeutics Limited
0.2000
-4.76%
 
SPL.AX Starpharma Holdings Limited
0.1150
0.00%
 
TYP.AX TRYPTAMINE FPO [TYP]
0.0420
0.00%
 
RAC.AX Race Oncology Limited
1.3900
0.00%